During the past decade, Tokushima University conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tokushima University" #1 collaborator was "Hiroshima University" with 1 trials as a collaborator, "Japan Agency for Medical Research and Development" with 1 trials as a collaborator, "Kitasato University" with 1 trials as a collaborator, "Nara Medical University" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Tokushima University" are "Amyotrophic Lateral Sclerosis" (1 trials), "Cerebrovascular and Cardiovascular Diseases" (1 trials) and "Kidney Neoplasms" (1 trials). Many other conditions were trialed in "Tokushima University" in a lesser frequency.

Most popular intervention types in "Tokushima University" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Any oral antithrombotics (antiplatelets or anticoagulants)" (1 trials), "Axitinib (AG-013736)" (1 trials), "Bosutinib (Phase 1 part)" (1 trials), "Bosutinib (Phase 2 part)" (1 trials) and "Sorafenib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tokushima University" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Tokushima University". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Tokushima University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Tokushima University, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".